Variant classification of hereditary cancer genes is affected by genomic underrepresentation of admixed populations
- 3 September 2025
- journal article
- research article
- Published by Springer Nature in Molecular Genetics and Genomics
- Vol. 300 (1) , 1-11
Abstract
Variant classification in genetic testing often culminates in “uncertain” calls, known as variants of uncertain significance (VUS), which remain a major clinical challenge. Among the established criteria for variant classification, population allele frequency (AF) is fundamental, yet under-representation of non-European groups hinders accurate interpretation. In this study, we evaluated the impact of population-specific AF on the reclassification of VUS and conflicting variants in hereditary cancer genes. From ClinVar, we curated 487 variants present in both the Brazilian cohort ABraOM and gnomAD v4.1 databases. Comparative population analysis revealed that 43% of shared variants showed significantly different AFs (q ≤ 0.01), with 113 (23%) exhibiting large effect sizes (OR ≥ 4), including 39 VUS. Among these, 20 VUS had higher AF in the Brazilian cohort and exceeded benignity thresholds (BS1), while remaining rare in other populations. Functional prediction tools such as REVEL and CADD failed to distinguish these variants from globally rare VUS. Integrating Brazilian‑specific AF with ClinGen VCEP rules downgraded 15% (3/20) of candidate VUS and resolved five conflicting calls. These findings argue for routine incorporation of regional reference datasets in diagnostic curation to reduce uncertainty and avoid inappropriate clinical management in diverse populations.Keywords
Funding Information
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (88882.434552/2019-01)
This publication has 36 references indexed in Scilit:
- Genomic disparity impacts variant classification of cancer susceptibility genes in Turkish breast cancer patientsCancer Medicine, 2024
- Rates and Classification of Variants of Uncertain Significance in Hereditary Disease Genetic TestingJAMA Network Open, 2023
- Variant interpretation using population databases: Lessons from gnomADHuman Mutation, 2021
- Biased pathogenic assertions of loss of function variants challenge molecular diagnosis of admixed individualsAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2021
- Genetic admixture in BrazilAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2020
- Yield and Utility of Germline Testing Following Tumor Sequencing in Patients With CancerJAMA Network Open, 2020
- Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With OsteosarcomaJAMA Oncology, 2020
- Improving the Understanding of Genetic Variants in Rare Disease With Large-scale Reference PopulationsJAMA, 2019
- ClinGen Variant Curation Expert Panel experiences and standardized processes for disease and gene‐level specification of the ACMG/AMP guidelines for sequence variant interpretationHuman Mutation, 2018
- Prevalence of Variant Reclassification Following Hereditary Cancer Genetic TestingJAMA, 2018